During the past decade, Saitama Medical Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 10 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 5 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saitama Medical Center" #1 sponsor was "Loxo Oncology, Inc." with 4 trials, followed by "Amgen" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Janssen Pharmaceutical K.K." with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Medical Center" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Saitama Medical University" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Saitama Medical Center" are "Rheumatoid Arthritis" (6 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Crohn's Disease" (3 trials), "Small Lymphocytic Lymphoma" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Saitama Medical Center" in a lesser frequency.

Most popular intervention types in "Saitama Medical Center" are "Drug" (29 trials), "Biological" (4 trials), "Device" (2 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Rituximab" (4 trials), "Carfilzomib" (3 trials), "Dexamethasone" (3 trials) and "Pirtobrutinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Saitama Medical Center" are 36 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saitama Medical Center". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Saitama Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saitama Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".